Report_CO633C28121373451682_2023_12_28_R_L

PROCESSED AT :
Thyrocare
UR House,
No. 1056C, Avinashi Road,
Coimbatore - 641018
NAME : VASUKI (41Y/F) SAMPLE COLLECTED AT :

REF. BY (6416054535),R S MICRO LAB,12VEERAPANDI
: SELF
PIRIVU BUS STOP MANGAL MEDICAL BACK SIDE
TEST ASKED : ESR,HbA1c,HEMOGRAM VEERAPANDI ROAD TIRUPUR 641605,641605
TEST NAME TECHNOLOGY VALUE UNITS

HbA1c - (HPLC)
H.P.L.C 5.6 %
Bio. Ref. Interval. :
Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics
Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 114 mg/dL
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values
Please correlate with clinical conditions.
Sample Collected on (SCT) : 28 Dec 2023 09:02
Sample Received on (SRT) : 28 Dec 2023 16:07

Report Released on (RRT) : 28 Dec 2023 18:34
Sample Type : EDTA
Labcode : 2812041489/CO633 Dr Lakshmikanth MD(Path) Dr Shwetha MD (Path)
Barcode : BP065420
Page : 1 of 24
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018

REF. BY : SELF (6416054535),R S MICRO LAB,12VEERAPANDI
TEST ASKED : ESR,HbA1c,HEMOGRAM
VEERAPANDI ROAD TIRUPUR 641605,641605

ERYTHROCYTE SEDIMENTATION RATE (ESR) WESTERGREN 28 mm / hr
Bio. Ref. Interval. :-
Male : 0-15
Female : 0-20

Method:- WESTERGREN

Sample Type : EDTA
Dr Lakshmikanth MD(Path) Dr Shwetha MD (Path)
Labcode : 2812041489/CO633
Barcode : BP065420 Page : 2 of 24
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018

TEST ASKED : ESR,HbA1c,HEMOGRAM
TEST NAME VALUE UNITS Bio. Ref. Interval.

TOTAL LEUCOCYTES COUNT (WBC) 6.97 X 10³ / µL 4.0 - 10.0
NEUTROPHILS 50.4 % 40-80
LYMPHOCYTE 39.6 % 20-40
MONOCYTES 4.7 % 2-10
EOSINOPHILS 4.3 % 1-6
BASOPHILS 0.9 % 0-2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.1 % 0.0-0.4
NEUTROPHILS - ABSOLUTE COUNT 3.51 X 10³ / µL 2.0-7.0
LYMPHOCYTES - ABSOLUTE COUNT 2.76 X 10³ / µL 1.0-3.0
MONOCYTES - ABSOLUTE COUNT 0.33 X 10³ / µL 0.2 - 1.0
BASOPHILS - ABSOLUTE COUNT 0.06 X 10³ / µL 0.02 - 0.1
EOSINOPHILS - ABSOLUTE COUNT 0.3 X 10³ / µL 0.02 - 0.5
IMMATURE GRANULOCYTES(IG) 0.01 X 10³ / µL 0.0-0.3
TOTAL RBC 4.87 X 10^6/µL 3.8-4.8
NUCLEATED RED BLOOD CELLS 0.01 X 10³ / µL 0.0-0.5
NUCLEATED RED BLOOD CELLS % 0.01 % 0.0-5.0
HEMOGLOBIN 12 g/dL 12.0-15.0
HEMATOCRIT(PCV) 39.2 % 36.0-46.0
MEAN CORPUSCULAR VOLUME(MCV) 80.5 fL 83.0-101.0
MEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.6 pq 27.0-32.0
MEAN CORP.HEMO.CONC(MCHC) 30.6 g/dL 31.5-34.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 46.5 fL 39.0-46.0
RED CELL DISTRIBUTION WIDTH (RDW-CV) 15.9 % 11.6-14.0
PLATELET DISTRIBUTION WIDTH(PDW) 10.7 fL 9.6-15.2
MEAN PLATELET VOLUME(MPV) 10.1 fL 6.5-12
PLATELET COUNT 462 X 10³ / µL 150-410
PLATELET TO LARGE CELL RATIO(PLCR) 24.3 % 19.7-42.4
PLATELETCRIT(PCT) 0.47 % 0.19-0.39
Remarks : Alert!!! RBCs:Mild anisopoikilocytosis. Predominantly normocytic normochromic with microcytes & ovalocytes. Platelets:Appear adequate in smear.
Please Correlate with clinical conditions.

Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow Cytometry Method
(using a semiconductor laser), and SLS- hemoglobin method)

Sample Type : EDTA
Barcode : BP065420 Page : 3 of 24
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018

TEST ASKED : AAROGYAM D PRO WITH UTSH,CRP

HOMOCYSTEINE PHOTOMETRY 5.89 µmol/L
Normal Levels : <15 µmol/L

Mild Hyperhomocysteinemia : 15-30 µmol/L
Moderate Hyperhomocysteinemia : 30-100 µmol/L
Severe Hyperhomocysteinemia : >100 µmol/L
Clinical Significance:
Homocysteine is linked to increased risk of premature coronary artery disease, stroke and thromboembolism. Moreover,
alzheimers disease, osteoporosis, venous thrombosis, schizophrenia, cognitive deficiency and pregnancy complications also
elevates Homocysteine levels.
High Values:
Elevated homocysteine levels might be due to increasing age, genetic traits, drugs, renal dysfunction and dietary deficiency of
vitamins or smoking. To lower your homocysteine, eat more green vegetables, stop smoking, alcohol. Folic acid helps lowering
elevated levels.
Specifications: Precision %CV :- Intra assay %CV- 4.5 % , Inter assay %CV-5.87 % Sensitivity : 0.4 umol/L
Kit Validation Reference:

Eikelboom JW, et al Ann Intern Med 131 : 363-75 (1999)
https://www.healthline.com/health/homocysteine-levels

Method:- ENZYMATIC ASSAY

Sample Type : SERUM
Labcode : 2812085139/CO633
Barcode : BN143040 Page : 4 of 24
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018

: SELF
TEST ASKED : AAROGYAM D PRO WITH UTSH,CRP VEERAPANDI ROAD TIRUPUR 641605,641605
25-OH VITAMIN D (TOTAL) E.C.L.I.A 10.8 ng/mL

Deficiency : <=20 ng/ml || Insufficiency : 21-29 ng/ml
Sufficiency : >= 30 ng/ml || Toxicity : >100 ng/ml
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical
for building bone health.
Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic syndrome.
Increase in vitamin D total levels indicate Vitamin D intoxication.
Specifications: Precision: Intra assay (%CV):9.20%, Inter assay (%CV):8.50%

Kit Validation Reference : Holick M. Vtamin D the underappreciated D-Lightful hormone that is important for Skeletal
and cellular health Curr Opin Endocrinol Diabetes 2002:9(1)87-98.
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay
VITAMIN B-12 E.C.L.I.A 418 pg/mL
Normal: 197-771 pg/ml
Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs
and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath.
Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For
diagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical examination and
other findings.
Specifications: Intra assay (%CV):2.6%, Inter assay (%CV):2.3 %
Kit Validation Reference : Thomas L.Clinical laborator Diagnostics : Use and Assessment of Clinical laboratory Results 1st Edition,TH
Books-Verl-Ges,1998:424-431
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

Sample Type : SERUM
Barcode : BN143040
Page : 5 of 24
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018

: SELF
APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 142 mg/dL

Male : 86 - 152
Female : 94 - 162
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 112 mg/dL
Male : 56 - 145
Female : 53 - 138
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APO B / APO A1 RATIO (APO B/A1) CALCULATED 0.8 Ratio
Male : 0.40 - 1.26
Female : 0.38 - 1.14
Method : DERIVED FROM SERUM APO A1 AND APO B VALUES

Sample Type : SERUM
Barcode : BN143040
Page : 6 of 24
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018


FOLATE C.L.I.A 14.7 ng/mL
> 5.38 ng/ml
Clinical Significance: Low folate intake, malabsorption as a result of gastrointestinal diseases, pregnancy, and drugs such as
phenytoin are causes of folate deficiency.3 Folate deficiency is also associated with chronic alcoholism. Serum folate measurement
provides an early index of folate status.
Specifications: Precision: Intra assay (%CV): 7.93, Inter assay (%CV): 7.19, Sensitivity: 0.35 ng/mL.
Kit Validation References: Steinkamp RC. Vitamin B12 and folic acid: clinical and pathophysiological considerations. In: Brewster
MA, Naito HK, eds. Nutritional Elements and Clinical Biochemistry. New York: Plenum Publishing Corp.; 1980:169–240

Method:- COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY

Sample Type : SERUM
Labcode : 2812085139/CO633
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018


HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 5.54 mg/L
< 1.00 - Low Risk

1.00 - 3.00 - Average Risk
>3.00 - 10.00 - High Risk
> 10.00 - Possibly due to Non-Cardiac Inflammation
Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as
infection , active arthritis or concurrent illness.
Clinical significance:
High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk
for future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP
tests, ideally taken two weeks apart.

1.Clinical management of laboratory date in medical practice 2003-3004, 207(2003).
2.Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.

Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

Sample Type : SERUM
Labcode : 2812085139/CO633
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018
SAMPLE COLLECTED AT :
NAME : VASUKI (41Y/F) (6416054535),R S MICRO LAB,12VEERAPANDI
REF. BY : SELF PIRIVU BUS STOP MANGAL MEDICAL BACK SIDE

C-REACTIVE PROTEIN (CRP) IMMUNOTURBIDIMETRY 5.53 mg/L
Bio. Ref. Interval. : (mg/L)
Acute phase determination : < 5 mg/L
It’s a protein present in the sera of acutely ill patients that bound cell wall C-polysaccharide of streptococcus
pneumoniae and agglutinates the organisms.
CRP is one of the strongest acute -phase reactants, with plasma concentrations rising up after myocardial
infarction,stress,trauma,infection,inflammation,surgery, or neoplastic proliferation.
Concentrations >5 to 10mg/L suggest the presence of an infection or inflammatory process. Concentrations
are generally higher in bacterial than viral infection. The increase in peak is proportional to tissue damage.
Determination of CRP is clinically useful to screen activity of inflammatory diseases such as rheumatoid
arthritis; SLE;Leukemia;after surgery;to detect rejection in renal allograft recipients;to detect neonatal
septicemia and meningitis. However, its is a nonspecific marker and cannot be interpreted without other

Sample Type : SERUM
Labcode Dr Lakshmikanth MD(Path) Dr Shwetha MD (Path)
: 2812085139/CO633
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018

: SELF
IRON PHOTOMETRY 98.05 µg/dL

Male : 65 - 175
Female : 50 - 170
Method : FERROZINE METHOD WITHOUT DEPROTEINIZATION
TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 374.7 µg/dL
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl
Method : SPECTROPHOTOMETRIC ASSAY
% TRANSFERRIN SATURATION CALCULATED 26.17 %
13 - 45
Method : DERIVED FROM IRON AND TIBC VALUES
UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 276.65 µg/dL
162 - 368
Method : SPECTROPHOTOMETRIC ASSAY
FERRITIN E.C.L.I.A 50.8 ng/mL
13 - 150
Method : Fully Automated Electrochemiluminescence Sandwich Immunoassay

Sample Type : SERUM
Barcode : BN143040
Page : 10 of 24
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018

: SELF
FRUCTOSAMINE PHOTOMETRY 254.66 µmol/L

Normal < 286 µmol/L
Fructosamine assay is useful in monitoring the degree of glycemia over short-to-intermediate time frames (1-3 weeks) concentration
greater than the established normal range is an indication of prolonged hyperglycemia of 1-3 weeks or longer. The higher
fructosamine value, poorer is the degree of glycemia control.
Specifications:
Precision %CV : Intra assay %CV- 3.2% , Inter assay %CV-4.0%, Sensitivity:- 290 umol/L
Howey JEA, Browning MCK, Fraser CG. Assay of serum fructosamine that minimizes standardization and matrix problems: Use to
assess components of biological va-riation. Clin Chem 1987; 33: 269- 272.
Method : NITROBLUE TETRAZOLIUM ASSAY (NBT)
BLOOD KETONE (D3HB) PHOTOMETRY 0.63 mg/dL
0.21-2.81 mg/dL
Three types of ketones can be produced in body D-3- Hydroxybutyrate, Acetoacetate and Acetone. D-3- Hydroxybutyrate accounts
for approximately 75% of the ketone bodies. During periods of ketosis, D-3- Hydroxybutyrate increases more than the other two. It
has been shown to be a better index of ketoacidosis. In diabetics, D-3- Hydroxybutyrate is needed for the assessment of the
severity of diabetic coma and to calculate insulin requirements.
Speficcation:
Precision: Intra assay (%CV): 4.53, Inter assay (%CV): 2.9, Sensitivity: 10.41 mg/dL.
Kit validation references:

Mcmurray, C.H., Blanchflower, W.J., Rice, D.A., ClinChem., 1984;30:No.3.
Method : ENZYMATIC (KINETIC)

Sample Type : SERUM
Barcode : BN143040
Page : 11 of 24
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018


LIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY > 100 mg/dL
Adults : < 30.0 mg/dl
Determination of LPA may be useful to guide management of individuals with a family history of CHD or with existing disease. The
levels of LPA in the blood depends on genetic factors; The range of variation in a population is relatively large and hence for
diagnostic purpose, results should always be assessed in conjunction with the patient’s medical history, clinical examination and
other findings.
Specifications:
Precision %CV :- Intra assay %CV- 4.55% , Inter assay %CV-0.86 %

Tietz NW,Clinical Guide to Laboratory Tests Philadelphia WB. Saunders 1995 : 442-444

Method:- LATEX ENHANCED IMMUNOTURBIDIMETRY

Sample Type : SERUM
Labcode : 2812085139/CO633
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018


SERUM COPPER PHOTOMETRY 137.59 µg/dL
Male : 63.5 - 150

Female : 80 - 155
Copper is an important trace element and a component of numerous enzymes and proteins involved in energy production,
connective tissue formation, melanin synthesis, iron metabolism, development of central nervous system, angiogenesis as well as
an antioxidant. Deficiency can cause- Malnourishment, cardiovascular disease, anemia & neuropathy, toxicity may be manifested
as acute renal failure, gastroenteritis & chronic liver disease.
Specifications:
Precision: Intra assay (%CV): 1.17, Inter assay (%CV): 2.32.
Kit validation references:

Thomas L. Clinical Laboratory Diagnostics. 1st ed. Frankfurt: TH-Books Verlagsgesellschaft; 1998. p. 337-8

Method:- 3,5-DIBR-PAESA

Sample Type : SERUM
Labcode : 2812085139/CO633
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018


SERUM ZINC PHOTOMETRY 58.16 µg/dL
52 - 286
Zinc is one of the essential trace elements in the body. Its metalloenzymes play a key rple in protein and nucleic acid synthesis,
gene expression, wound healing, as an antioxidant, etc. Deficiency can cause- Poor wound healing, gastroenteritis, impaired
spermatogenesis, Alzheimer’s disease, etc. Toxicity may be manifested as pancreatitis, gastric ulcer, anemia, pulmonary fibrosis.
Specifications:
Precision: Intra assay (%CV): 2.02, Inter assay (%CV): 2.22.
Kit Validation References:

Thomas L. Clinical Laboratory Diagnostics. 1st ed. Frankfurt: TH-Books Verlagsgesellschaft; 1998. p. 347-9

Method:- NITRO - PAPS

Sample Type : SERUM
Labcode : 2812085139/CO633
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018


TESTOSTERONE E.C.L.I.A 14.3 ng/dL
6 - 82
Clinical Significance: Clinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males.
Major causes of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,
Hypopituitarism some types of liver and kidney diseases and critical illness.
Specifications: Precision: Intra assay (%CV): 11.50 %, Inter assay (%CV): 5.70%; Sensitivity: 7 ng/dL.
Kit Validation Reference: Wilson JD Foster DW (Eds) Williams Textbook of Endocrinology 8th Edition WB Saunders Piladelphia
Pennsylvania.
Note : The Biological Reference Range mentioned is specific to the age group and gender. Kindly correlate clinically.

Method:- Fully Automated Electrochemiluminescence Compititive Immunoassay

Sample Type : SERUM
Labcode : 2812085139/CO633
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018


AMYLASE PHOTOMETRY 56.2 U/L
Adults : 28-100 U/L
Interpretation:
Lipemic Sera (Hypertriglyceridemia) may contain inhibitors, Which falsely depress results. About 20% of patients with Acute
Pancreatitis have abnormal lipids. Normal serum amylase may occur in Pancreatitis, Especially relapsing and chronic pancreatitis.
Moderate increases may be reported in normal pregnancy.
Causes of high Serum Amylase include Acute Pancreatitis, Pancreatic Pseudocyst, Pancreatic Ascites, Pancreatic Abscess,
Neoplasm in or adjacent to Pancreas, Trauma to Pancreas, and common Duct Stones. Nonpancreatic Causes include inflammatory
salivary lesions (Eg, Mumps), Perforated Peptic Ulcer, Intestinal Obstruction, Biliary Tract Disease, Peritonitis, Acute Appendicitis,
Diabetic Ketoacidosis, and Extrapancreatic Carcinomas. Amylase levels more than 25-fold the upper limit of normal are often found
when metastatic tumors produce Ectopic Amylase.
Specifications:
Precision: Intra assay (%CV): 2.82, Inter assay (%CV): 2.49, Sensitivity: 10.9 U/L.

Rauscher, E., et coll., Fresenius Z. Analyt. Chem. 324 (1986) 304-305.

Method:- ENZYMATIC COLORIMETRIC TEST

Sample Type : SERUM
Labcode : 2812085139/CO633
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018


LIPASE PHOTOMETRY 26.6 U/L
Adults : 5.6 - 51.3 U/L
Interpretation:
For diagnostic purposes, the results should always be assessed in conjunction with the patient’s medical history, clinical
examination and other findings like serum amylase. Serum Lipase is usually normal in patients with elevated serum amylase,
having peptic ulcer, salivary adenitis, inflammatory bowel disease, intestinal obstruction, and macroamylasemia. Lipemic sera may
interfere with results.
High serum Lipase is a specific marker for pancreatitis; after acute pancreatitis the Lipase activity increases within 4-8 hours,
reaches a peak after 24 hours and decreases after 8 to 14 days. However, there is no correlation between the Lipase activity
determined in serum and the extent of damage to the pancreas.
Specifications:
Precision: Intra assay (%CV): 3.35, Inter assay (%CV): 2.46, Sensitivity: 3.5 U/L.

Tietz Nw Et Al. Lipase In Serum - The Elusive Enzyme: An Overview. Clin Chem 1993; 39:746-756.

Method:- ENZYMATIC COLORIMETRIC ASSAY

Sample Type : SERUM
Labcode : 2812085139/CO633
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018

REF. BY (6416054535),R S MICRO LAB,12VEERAPANDI PIRIVU
: SELF
BUS STOP MANGAL MEDICAL BACK SIDE VEERAPANDI
TEST ASKED : AAROGYAM D PRO WITH UTSH,CRP ROAD TIRUPUR 641605,641605
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 267 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 66 mg/dL 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 179 mg/dL < 100
TRIGLYCERIDES PHOTOMETRY 93 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 4.1 Ratio 3-5
LDL / HDL RATIO CALCULATED 2.7 Ratio 1.5-3.5
VLDL CHOLESTEROL CALCULATED 18.56 mg/dL 5 - 40
HDL / LDL RATIO CALCULATED 0.37 Ratio > 0.40
TRIG / HDL RATIO CALCULATED 1.42 Ratio < 3.12
NON-HDL CHOLESTEROL CALCULATED 201.76 mg/dL < 160
Method :
CHOL - CHOLESTEROL OXIDASE, ESTERASE, PEROXIDASE
HCHO - DIRECT ENZYMATIC COLORIMETRIC
LDL - DIRECT MEASURE
TRIG - ENZYMATIC, END POINT
TC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
LDL/ - DERIVED FROM SERUM HDL AND LDL VALUES
VLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES
HD/LD - DERIVED FROM HDL AND LDL VALUES.
TRI/H - DERIVED FROM TRIG AND HDL VALUES
NHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)
DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
BORDERLINE HIGH
HIGH >240 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Type : SERUM

PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018

: SELF

ALKALINE PHOSPHATASE PHOTOMETRY 61.32 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.96 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.22 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.74 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 12.41 U/L < 38
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 21.51 U/L < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 22.81 U/L < 34
SGOT / SGPT RATIO CALCULATED 0.94 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 7.56 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.47 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 3.09 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.45 Ratio 0.9 - 2
Method :
ALKP - MODIFIED IFCC METHOD
BILT - VANADATE OXIDATION
BILD - VANADATE OXIDATION
BILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES
GGT - MODIFIED IFCC METHOD
SGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
SGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
OT/PT - DERIVED FROM SGOT AND SGPT VALUES.
PROT - BIURET METHOD
SALB - ALBUMIN BCG¹METHOD (COLORIMETRIC ASSAY ENDPOINT)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES

Sample Type : SERUM

PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018


MAGNESIUM PHOTOMETRY 1.94 mg/dL
1.90 - 3.10 mg/dL
Magnesium is the fourth most abundant cation in the body and second most prevalent intracellular cation. The total body
magnesium content is about 25 g or approximately 1 mol, of which 55% reside in the skeleton. About 45% of the magnesium is
intracellular. In general higher the metabolic activity of cell, the greater is its magnesium content. Magnesium is a cofactor for
more than 300 enzymes in the body.
Disorders of magnesium metabolism are separated into those causing hypomagnesaemia/magnesium deficiencies and
hypermagnesemia. Hypomagnesaemia is common in patient in hospitals. Moderate to severe deficiency of magnesium is usually
due to loss of magnesium from the gastrointestinal (gi) tract or kidneys. One of the more serious complications of magnesium
deficiency is cardiac arrhythmia. Symptomatic hypermagnsemia is almost always caused by excessive intake, resulting from
administration of antacids, enemas, and parenteral fluids containing magnesium. Depression of neuromuscular system is the most
common manifestation of magnesium intoxication.
External quality control program participation:
College Of American Pathologists: Chemistry survey; CAP Number: 7193855-01

Method:- MODIFIED XYLIDYL BLUE REACTION METHOD

Sample Type : SERUM
Labcode : 2812085139/CO633
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018

: SELF

BLOOD UREA NITROGEN (BUN) PHOTOMETRY 5.04 mg/dL 7.94 - 20.07
CREATININE - SERUM PHOTOMETRY 0.52 mg/dL 0.55-1.02
BUN / SR.CREATININE RATIO CALCULATED 9.69 Ratio 9:1-23:1
CALCIUM PHOTOMETRY 8.8 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 4.11 mg/dL 3.2 - 6.1
UREA (CALCULATED) CALCULATED 10.79 mg/dL Adult : 17-43
UREA / SR.CREATININE RATIO CALCULATED 20.74 Ratio < 52
SODIUM I.S.E 137 mmol/L 136 - 145
CHLORIDE I.S.E 102.6 mmol/L 98 - 107
Method :
BUN - KINETIC UV ASSAY.
SCRE - CREATININE ENZYMATIC METHOD
B/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES
CALC - ARSENAZO III METHOD, END POINT.
URIC - URICASE / PEROXIDASE METHOD
UREAC - DERIVED FROM BUN VALUE.
UR/CR - DERIVED FROM UREA AND SR.CREATININE VALUES.
SOD - ION SELECTIVE ELECTRODE
CHL - ION SELECTIVE ELECTRODE

Sample Type : SERUM

PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018

(6416054535),R S MICRO LAB,12VEERAPANDI PIRIVU
REF. BY : SELF

TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 109 ng/dL 80-200
TOTAL THYROXINE (T4) E.C.L.I.A 8.22 µg/dL 4.8-12.7
TSH - ULTRASENSITIVE E.C.L.I.A 2.07 µIU/mL 0.54-5.30
Comments : ***
The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :
T3,T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay

USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay
Pregnancy reference ranges for TSH/USTSH :
Trimester || T3 (ng/dl) || T4 (µg/dl) || TSH/USTSH (µIU/ml)
1st || 83.9-196.6 || 4.4-11.5 || 0.1-2.5
2nd || 86.1-217.4 || 4.9-12.2 || 0.2-3.0
3rd || 79.9-186 || 5.1-13.2 || 0.3-3.5
References :
1. Carol Devilia, C I Parhon. First Trimester Pregnancy ranges for Serum TSH and Thyroid Tumor reclassified as
Benign. Acta Endocrinol. 2016; 12(2) : 242 - 243
2. Kulhari K, Negi R, Kalra DK et al. Establishing Trimester specific Reference ranges for thyroid hormones in Indian
women with normal pregnancy : New light through old window. Indian Journal of Contemporary medical research.
2019; 6(4)
Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Type : SERUM
PROCESSED AT :
Thyrocare
UR House,
Coimbatore - 641018


EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 119 mL/min/1.73 m2
> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease
Clinical Significance
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.
Reference
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Method:- CKD-EPI Creatinine Equation
~~ End of report ~~

Sample Type : SERUM
Labcode : 2812085139/CO633
CONDITIONS OF REPORTING
v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage that
may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00
EXPLANATIONS
v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.
SUGGESTIONS
v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333
*As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)
Page : 24 of 24

Report_CO633C28121373451682_2023_12_28_R_L

Uploaded by

Copyright:

Available Formats

Report_CO633C28121373451682_2023_12_28_R_L

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Report_CO633C28121373451682_2023_12_28_R_L

Uploaded by

Copyright:

Available Formats

PROCESSED AT :

NAME : VASUKI (41Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

Below 5.7% : Normal Below 6.5% : Good Control

Sample Collected on (SCT) : 28 Dec 2023 09:02

Sample Received on (SRT) : 28 Dec 2023 16:07

NAME : VASUKI (41Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

Please correlate with clinical conditions.

Sample Collected on (SCT) : 28 Dec 2023 09:02

NAME : VASUKI (41Y/F) SAMPLE COLLECTED AT :

TEST NAME VALUE UNITS Bio. Ref. Interval.

Please Correlate with clinical conditions.

Sample Collected on (SCT) : 28 Dec 2023 09:02

NAME : VASUKI (41Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

Normal Levels : <15 µmol/L

Kit Validation Reference:

Please correlate with clinical conditions.

Sample Collected on (SCT) : 28 Dec 2023 09:02

NAME : VASUKI (41Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) E.C.L.I.A 10.8 ng/mL

Specifications: Precision: Intra assay (%CV):9.20%, Inter assay (%CV):8.50%

Specifications: Intra assay (%CV):2.6%, Inter assay (%CV):2.3 %

Sample Collected on (SCT) : 28 Dec 2023 09:02

Sample Received on (SRT) : 28 Dec 2023 15:54

NAME : VASUKI (41Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 142 mg/dL

Sample Collected on (SCT) : 28 Dec 2023 09:02

Sample Received on (SRT) : 28 Dec 2023 15:54

NAME : VASUKI (41Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

> 5.38 ng/ml

Please correlate with clinical conditions.

Sample Collected on (SCT) : 28 Dec 2023 09:02

NAME : VASUKI (41Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

< 1.00 - Low Risk

Kit Validation Reference:

Please correlate with clinical conditions.

Sample Collected on (SCT) : 28 Dec 2023 09:02

TEST NAME TECHNOLOGY VALUE UNITS

Please correlate with clinical conditions.

Sample Collected on (SCT) : 28 Dec 2023 09:02

NAME : VASUKI (41Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 98.05 µg/dL

Sample Collected on (SCT) : 28 Dec 2023 09:02

Sample Received on (SRT) : 28 Dec 2023 15:54

NAME : VASUKI (41Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

FRUCTOSAMINE PHOTOMETRY 254.66 µmol/L

Normal < 286 µmol/L

Kit Validation Reference:

Kit validation references:

Sample Collected on (SCT) : 28 Dec 2023 09:02

Sample Received on (SRT) : 28 Dec 2023 15:54

NAME : VASUKI (41Y/F) SAMPLE COLLECTED AT :